320 related articles for article (PubMed ID: 16372351)
21. Costello syndrome: clinical diagnosis in the first year of life.
Digilio MC; Sarkozy A; Capolino R; Chiarini Testa MB; Esposito G; de Zorzi A; Cutrera R; Marino B; Dallapiccola B
Eur J Pediatr; 2008 Jun; 167(6):621-8. PubMed ID: 17726614
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
[TBL] [Abstract][Full Text] [Related]
23. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
[TBL] [Abstract][Full Text] [Related]
24. Leukemia in Cardio-facio-cutaneous (CFC) syndrome: a patient with a germline mutation in BRAF proto-oncogene.
Makita Y; Narumi Y; Yoshida M; Niihori T; Kure S; Fujieda K; Matsubara Y; Aoki Y
J Pediatr Hematol Oncol; 2007 May; 29(5):287-90. PubMed ID: 17483702
[TBL] [Abstract][Full Text] [Related]
25. Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation.
Denayer E; Parret A; Chmara M; Schubbert S; Vogels A; Devriendt K; Frijns JP; Rybin V; de Ravel TJ; Shannon K; Cools J; Scheffzek K; Legius E
Hum Mutat; 2008 Feb; 29(2):232-9. PubMed ID: 17979197
[TBL] [Abstract][Full Text] [Related]
26. Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies for Noonan, cardio-facio-cutaneous and Costello syndromes.
Tartaglia M; Cotter PD; Zampino G; Gelb BD; Rauen KA
Clin Genet; 2003 May; 63(5):423-6. PubMed ID: 12752577
[TBL] [Abstract][Full Text] [Related]
27. Skeletal muscle pathology in Costello and cardio-facio-cutaneous syndromes: developmental consequences of germline Ras/MAPK activation on myogenesis.
Tidyman WE; Lee HS; Rauen KA
Am J Med Genet C Semin Med Genet; 2011 May; 157C(2):104-14. PubMed ID: 21495178
[TBL] [Abstract][Full Text] [Related]
28. Hepatoblastoma and heart transplantation in a patient with cardio-facio-cutaneous syndrome.
Al-Rahawan MM; Chute DJ; Sol-Church K; Gripp KW; Stabley DL; McDaniel NL; Wilson WG; Waldron PE
Am J Med Genet A; 2007 Jul; 143A(13):1481-8. PubMed ID: 17567882
[TBL] [Abstract][Full Text] [Related]
29. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
Seemanová E; Zenker M
Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
[TBL] [Abstract][Full Text] [Related]
30. Male-to-male transmission of Costello syndrome: G12S HRAS germline mutation inherited from a father with somatic mosaicism.
Sol-Church K; Stabley DL; Demmer LA; Agbulos A; Lin AE; Smoot L; Nicholson L; Gripp KW
Am J Med Genet A; 2009 Mar; 149A(3):315-21. PubMed ID: 19206176
[TBL] [Abstract][Full Text] [Related]
31. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
Bertola D; Buscarilli M; Stabley DL; Baker L; Doyle D; Bartholomew DW; Sol-Church K; Gripp KW
Am J Med Genet A; 2017 May; 173(5):1309-1318. PubMed ID: 28371260
[TBL] [Abstract][Full Text] [Related]
32. Germline mutations in HRAS proto-oncogene cause Costello syndrome.
Aoki Y; Niihori T; Kawame H; Kurosawa K; Ohashi H; Tanaka Y; Filocamo M; Kato K; Suzuki Y; Kure S; Matsubara Y
Nat Genet; 2005 Oct; 37(10):1038-40. PubMed ID: 16170316
[TBL] [Abstract][Full Text] [Related]
33. Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome.
Gripp KW; Stabley DL; Geller PL; Hopkins E; Stevenson DA; Carey JC; Sol-Church K
Am J Med Genet A; 2011 Sep; 155A(9):2263-8. PubMed ID: 21834037
[TBL] [Abstract][Full Text] [Related]
34. Transmission of the rare HRAS mutation (c. 173C > T; p.T58I) further illustrates its attenuated phenotype.
Gripp KW; Hopkins E; Serrano A; Leonard NJ; Stabley DL; Sol-Church K
Am J Med Genet A; 2012 May; 158A(5):1095-101. PubMed ID: 22488832
[TBL] [Abstract][Full Text] [Related]
35. A novel patient with an attenuated Costello syndrome phenotype due to an HRAS mutation affecting codon 146-Literature review and update.
Chiu AT; Leung GK; Chu YW; Gripp KW; Chung BH
Am J Med Genet A; 2017 Apr; 173(4):1109-1114. PubMed ID: 28328122
[TBL] [Abstract][Full Text] [Related]
36. Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
Gremer L; De Luca A; Merbitz-Zahradnik T; Dallapiccola B; Morlot S; Tartaglia M; Kutsche K; Ahmadian MR; Rosenberger G
Hum Mol Genet; 2010 Mar; 19(5):790-802. PubMed ID: 19995790
[TBL] [Abstract][Full Text] [Related]
37. Phenotypic and Genetic Characteristics of Five Korean Patients with Costello Syndrome.
Choi N; Ko JM; Shin SH; Kim EK; Kim HS; Song MK; Choi CW
Cytogenet Genome Res; 2019; 158(4):184-191. PubMed ID: 31394527
[TBL] [Abstract][Full Text] [Related]
38. Severe neonatal manifestations of Costello syndrome.
Lo IF; Brewer C; Shannon N; Shorto J; Tang B; Black G; Soo MT; Ng DK; Lam ST; Kerr B
J Med Genet; 2008 Mar; 45(3):167-71. PubMed ID: 18039947
[TBL] [Abstract][Full Text] [Related]
39. [Mutations in H-Ras proto-oncogen in Costello syndrome].
Dereure O
Ann Dermatol Venereol; 2006; 133(8-9 Pt 1):731. PubMed ID: 17053754
[No Abstract] [Full Text] [Related]
40. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations.
Gripp KW; Lin AE
Genet Med; 2012 Mar; 14(3):285-92. PubMed ID: 22261753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
